Navigation Links
Antigen Express' AE37 Cancer Vaccine Featured in Scientific American
Date:9/21/2011

ration

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.  Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequentl
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
3. Medicago succesfully expresses VLP antigen for A H1N1 strain
4. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
5. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
6. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
7. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
8. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
9. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
10. Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology
11. Generex Provides Update on Spinout of Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... and ROCKVILLE, Md., Sept. 30, 2014 ... partnership focusing on commercializing market-relevant biohealth innovations and increasing ... , announced today that venture capitalist, Tania ... a strategic advisor. Dr. Fernandez will be a member ... Fund, which will provide up to $50 million in ...
(Date:9/30/2014)... 30, 2014 Lyme Research Alliance ... Lyme disease research at universities, today announced the awarding ... the identification, treatment and cure for Lyme and other ... the most applications in its history—over 20 grant proposals—a ... we were pleased to receive so many solid applications ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Whitehouse ... been chosen by the Parenteral Drug Association (PDA) ... and 19, 2014) on container closure integrity testing. This ... integrity test methods and philosophies detailed in the recently ... Evaluation. The course will span container closure ...
(Date:9/29/2014)... the start of the military conflicts in Iraq and ... United States with traumatic brain injury caused by exposure ... improvised explosive devices, or IEDs. Symptoms of traumatic brain ... headaches and nausea, to more severe impairments in memory ... of Defense has recognized the critical importance and complexity ...
Breaking Biology Technology:Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4
... - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS), today ... Listing Qualifications Department of The NASDAQ Stock Market indicating ... 5550(a)(2). , We plan to request a hearing before ... the NASDAQ,s determination of the continued listing of our ...
... new device, called a "spaser," is the first of ... critical component for possible future technologies based on "nanophotonic" ... Professor of Electrical and Computer Engineering at Purdue University. ... current lasers can,t be made small enough to integrate ...
... fixture, it,s time to take a fresh look at it. ... biosensors that can detect certain harmful toxins that can cause ... a paper published in the July issue of Analytical ... University, working with the Sentinel Bioactive Paper Network, describe a ...
Cached Biology Technology:Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 2New nanolaser key to future optical computers and technologies 2New nanolaser key to future optical computers and technologies 3Toxin detection as close as an inkjet printer 2
(Date:9/30/2014)... tetrachloroethylene (PCE) in drinking water may increase the ... a new study led by a Boston University ... published in the journal Environmental Health , ... among 1,766 women in Cape Cod, Ma., where ... the early 1980s by the installation of vinyl-lined ...
(Date:9/30/2014)... on Earth, but when the climate changes and temperatures ... The amount of time needed to adjust to new ... in the future, reveals a new study from researchers ... journal Proceedings of the Royal Society B . ... of greenhouse gases in the atmosphere. The greenhouse effect ...
(Date:9/30/2014)... N.C. -- Pollution in urban and farm runoff in ... new study finds. , The study, published Tuesday ... that nitrogen in the runoff ends up in algae ... on the animals, eyes, flippers and internal organs. , ... the National Oceanic and Atmospheric Administration (NOAA) conducted the ...
Breaking Biology News(10 mins):Contaminated water linked to pregnancy complications, BU study finds 2Shape up quickly -- applies to fish, too! 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... soy foods may be more effective in preventing prostate cancer ... alone, said a University of Illinois study. "In our ... an aggressive form of prostate cancer. Even so, half the ... lesions in the prostate at study,s end. All the mice ...
... people are familiar with the sight-saving role ophthalmologists play in ... of the revolutionary contributions they make beyond medicine. One such ... Flom , M.D., and the late Aran ... States Patent and Trademark Office,s National Inventors Hall of ...
... from the University of New South Wales have ... how micro-organisms respond to the disinfecting properties of ... applications. Although nanosilver has effective antimicrobial properties ... cause other potentially harmful organisms to rapidly adapt ...
Cached Biology News:Soy and tomato combo may be effective in preventing prostate cancer 2Ophthalmologist Inventors of Human Identification Technology Inducted into National Inventors Hall of Fame 2Ophthalmologist Inventors of Human Identification Technology Inducted into National Inventors Hall of Fame 3Bacteria adapt and evade nanosilver's sting -- new study 2
... Source: Crotalus adamanteus venom Description: ... widely used in studying nucleic ... . It hydrolyzes 5'-mononucleotides from ... . Phosphodiesterase I cleaves ADP-ribosylated ...
... Life Science Rotarods are used to assess the ... fatigue resistance on mice and rats using one ... user friendly; the animals are placed on textured ... onto the individual sensing platforms below, its test ...
... I Amplification Grade digests ... to oligodeoxyribonucleotides. The specific ... DNAse I Amplification Grade ... tested for absence of ...
... Qualified is a special preparation of bovine pancreatic ... stranded cleavage of DNA molecules. In the presence ... makes double strand breaks at random sites in ... can be controlled by the enzyme concentration and ...
Biology Products: